[Toxic-allergic lung edema following cyclophosphamide and ifosfamide therapy. Case report].
D000971:Antineoplastic Combined Chemotherapy Protocols; D018288:Carcinoma, Small Cell / Q000188:drug therapy / Q000556:secondary*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D004317:Doxorubicin / Q000008:administration & dosage; D004342:Drug Hypersensitivity / Q000175:diagnosis*; D004359:Drug Therapy, Combination; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects*; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011654:Pulmonary Edema / Q000139:chemically induced*; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D007069:Ifosfamide
Toxisch-allergisches Lungenödem nach Cyclophosphamid- und Ifosfamid-Therapie. Ein Fallbericht.